Cargando…
Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program
Genomic profiling programs have been implemented to apply next-generation sequencing (NGS) for facilitating trial enrollment. SCRUM-Japan GI-SCREEN is a large-scale genomic profiling program in advanced gastrointestinal cancers using a validated genomic assay with the goal of facilitating enrollment...
Autores principales: | Nakamura, Yoshiaki, Yamashita, Riu, Okamoto, Wataru, Komatsu, Yoshito, Yuki, Satoshi, Ueno, Makoto, Kato, Ken, Taniguchi, Hiroya, Kagawa, Yoshinori, Denda, Tadamichi, Hara, Hiroki, Esaki, Taito, Moriwaki, Toshikazu, Sunakawa, Yu, Oki, Eiji, Nagashima, Fumio, Nishina, Tomohiro, Satoh, Taroh, Kawakami, Hisato, Yamaguchi, Kensei, Ohtsubo, Koushiro, Kato, Takeshi, Horita, Yosuke, Tsuji, Akihito, Yasui, Hisateru, Goto, Masahiro, Hamamoto, Yasuo, Wakabayashi, Masashi, Ikeno, Takashi, Shitara, Kohei, Bando, Hideaki, Tsuchihara, Katsuya, Miki, Izumi, Ichiki, Hiroko, Ohtsu, Atsushi, Yoshino, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309536/ https://www.ncbi.nlm.nih.gov/pubmed/36996376 http://dx.doi.org/10.1200/PO.22.00653 |
Ejemplares similares
-
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy
por: Nakamura, Yoshiaki, et al.
Publicado: (2022) -
Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy
por: Aoki, Yu, et al.
Publicado: (2023) -
Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in
RAS
wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study
por: Yuki, Satoshi, et al.
Publicado: (2023) -
SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors
por: Nakamura, Yoshiaki, et al.
Publicado: (2021) -
Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer
por: Jogo, Tomoko, et al.
Publicado: (2021)